Big pharma shifting trial focus to US at expense of Asia; Parexel
Strategic clients increasingly want to outsource trials to the ‘old world’ of the US and Europe at the expense of Asia, Parexel said.
Strategic clients increasingly want to outsource trials to the ‘old world’ of the US and Europe at the expense of Asia, Parexel said.
Cytovance Biologics has added a 1,000L bioreactor at its Oklahoma site to support scale-up as clients move through clinical trials.
The resignation of CEO Axel Muller was a mutual decision and not linked to delayed efforts to win European approval for the asthma drug Flutiform says delivery tech firm SkyePharma.
Drugmaker Watson Pharmaceuticals has broke grounds on an R&D lab in New Jersey, US.
Pfizer is recalling 28 lots of contraceptives after a blister packaging error raised the risk of unintended pregnancy.
Food ingredients and flavours firm Kerry Group is to build a cell culture and media development lab for the pharmaceutical biomanufacuturing sector.
Encap Drug Delivery has won a contract manufacturing deal for a European licensed liquid-filled capsule product after the owner parted from its current CMO.